Global Cell and Gene Therapy CDMO Services Supply, Demand and Key Producers, 2024-2030

Description

Cell and   Gene Therapy Contract Development and Manufacturing Organization (CDMO)   services involve companies providing specialized expertise and infrastructure   for the development, manufacturing, and commercialization of cell and gene   therapy products on behalf of biopharmaceutical companies. These services   encompass a range of activities, including process development, analytical   testing, regulatory support, and manufacturing at various scales, from   preclinical to commercial production. CDMOs play a critical role in   accelerating the translation of cell and gene therapies from research to   clinical application by offering tailored solutions to meet the unique   requirements of each therapy, ultimately helping to bring innovative   treatments to patients more efficiently and effectively.

The global Cell and Gene Therapy CDMO Services market size is expected to reach $ 42240 million by 2030, rising at a market growth of 32.1% CAGR during the forecast period (2024-2030).

Due to complex technical mechanisms, high-threshold process development and large-scale production, strict regulatory requirements, and limited industrialization experience, CGT products are more dependent on CDMOs than traditional pharmaceuticals. Its outsourcing penetration rate exceeds 65%, far exceeding 35% of traditional biologics.

Considering that the production of viral vectors as the core involves very complex processes, is extremely difficult, and has a long preparation cycle, it is expected that the outsourcing rate of CGT will remain high in the future.

This report studies the global Cell and Gene Therapy CDMO Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy CDMO Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy CDMO Services total market, 2019-2030, (USD Million)
Global Cell and Gene Therapy CDMO Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell and Gene Therapy CDMO Services total market, key domestic companies, and share, (USD Million)
Global Cell and Gene Therapy CDMO Services revenue by player, revenue and market share 2019-2024, (USD Million)
Global Cell and Gene Therapy CDMO Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell and Gene Therapy CDMO Services total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Cell and Gene Therapy CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Lonza, Thermo Fisher, WuXi AppTec, Charles River, OxfordBioMedica, BrammerBio, CELLfor CURE, OBiO Technology, GenScript, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Gene Therapy CDMO Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell and Gene Therapy CDMO Services Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy CDMO Services Market, Segmentation by Type
    Autologous Cell Therapy Products
    Allogeneic Cell Therapy Products

Global Cell and Gene Therapy CDMO Services Market, Segmentation by Application:
    SMBs
    Large Companies

Companies Profiled:
    Catalent
    Lonza
    Thermo Fisher
    WuXi AppTec
    Charles River
    OxfordBioMedica
    BrammerBio
    CELLfor CURE
    OBiO Technology
    GenScript
    Esco
    Nikon
    FUJIFILM
    Pharmaron
    Porton
    Medicilon
    JOINN Laboratories
    Sofpromed
    eXmoor
    OmniaBio
    RoslinCT
    BioCentriq
    PolTREG
    Miltenyi Bioindustry

Key Questions Answered
1. How big is the global Cell and Gene Therapy CDMO Services market?
2. What is the demand of the global Cell and Gene Therapy CDMO Services market?
3. What is the year over year growth of the global Cell and Gene Therapy CDMO Services market?
4. What is the total value of the global Cell and Gene Therapy CDMO Services market?
5. Who are the Major Players in the global Cell and Gene Therapy CDMO Services market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy CDMO Services Introduction
    1.2 World Cell and Gene Therapy CDMO Services Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell and Gene Therapy CDMO Services Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy CDMO Services Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030)
        1.3.3 China Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030)
        1.3.4 Europe Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030)
        1.3.5 Japan Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030)
        1.3.6 South Korea Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030)
        1.3.7 ASEAN Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030)
        1.3.8 India Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy CDMO Services Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)
    2.2 World Cell and Gene Therapy CDMO Services Consumption Value by Region
        2.2.1 World Cell and Gene Therapy CDMO Services Consumption Value by Region (2019-2024)
        2.2.2 World Cell and Gene Therapy CDMO Services Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)
    2.4 China Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)
    2.5 Europe Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)
    2.6 Japan Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)
    2.7 South Korea Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)
    2.8 ASEAN Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)
    2.9 India Cell and Gene Therapy CDMO Services Consumption Value (2019-2030)

3 World Cell and Gene Therapy CDMO Services Companies Competitive Analysis
    3.1 World Cell and Gene Therapy CDMO Services Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy CDMO Services Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy CDMO Services in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy CDMO Services in 2023
    3.3 Cell and Gene Therapy CDMO Services Company Evaluation Quadrant
    3.4 Cell and Gene Therapy CDMO Services Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy CDMO Services Market: Region Footprint
        3.4.2 Cell and Gene Therapy CDMO Services Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy CDMO Services Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy CDMO Services Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy CDMO Services Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy CDMO Services Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy CDMO Services Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell and Gene Therapy CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell and Gene Therapy CDMO Services Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell and Gene Therapy CDMO Services Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy CDMO Services Revenue, (2019-2024)
    4.4 China Based Companies Cell and Gene Therapy CDMO Services Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell and Gene Therapy CDMO Services Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy CDMO Services Revenue, (2019-2024)
    4.5 Rest of World Based Cell and Gene Therapy CDMO Services Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell and Gene Therapy CDMO Services Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy CDMO Services Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy CDMO Services Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Autologous Cell Therapy Products
        5.2.2 Allogeneic Cell Therapy Products
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024)
        5.3.2 World Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030)
        5.3.3 World Cell and Gene Therapy CDMO Services Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy CDMO Services Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 SMBs
        6.2.2 Large Companies
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024)
        6.3.2 World Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030)
        6.3.3 World Cell and Gene Therapy CDMO Services Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Catalent
        7.1.1 Catalent Details
        7.1.2 Catalent Major Business
        7.1.3 Catalent Cell and Gene Therapy CDMO Services Product and Services
        7.1.4 Catalent Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Catalent Recent Developments/Updates
        7.1.6 Catalent Competitive Strengths & Weaknesses
    7.2 Lonza
        7.2.1 Lonza Details
        7.2.2 Lonza Major Business
        7.2.3 Lonza Cell and Gene Therapy CDMO Services Product and Services
        7.2.4 Lonza Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Lonza Recent Developments/Updates
        7.2.6 Lonza Competitive Strengths & Weaknesses
    7.3 Thermo Fisher
        7.3.1 Thermo Fisher Details
        7.3.2 Thermo Fisher Major Business
        7.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Product and Services
        7.3.4 Thermo Fisher Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Thermo Fisher Recent Developments/Updates
        7.3.6 Thermo Fisher Competitive Strengths & Weaknesses
    7.4 WuXi AppTec
        7.4.1 WuXi AppTec Details
        7.4.2 WuXi AppTec Major Business
        7.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Product and Services
        7.4.4 WuXi AppTec Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 WuXi AppTec Recent Developments/Updates
        7.4.6 WuXi AppTec Competitive Strengths & Weaknesses
    7.5 Charles River
        7.5.1 Charles River Details
        7.5.2 Charles River Major Business
        7.5.3 Charles River Cell and Gene Therapy CDMO Services Product and Services
        7.5.4 Charles River Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Charles River Recent Developments/Updates
        7.5.6 Charles River Competitive Strengths & Weaknesses
    7.6 OxfordBioMedica
        7.6.1 OxfordBioMedica Details
        7.6.2 OxfordBioMedica Major Business
        7.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Product and Services
        7.6.4 OxfordBioMedica Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 OxfordBioMedica Recent Developments/Updates
        7.6.6 OxfordBioMedica Competitive Strengths & Weaknesses
    7.7 BrammerBio
        7.7.1 BrammerBio Details
        7.7.2 BrammerBio Major Business
        7.7.3 BrammerBio Cell and Gene Therapy CDMO Services Product and Services
        7.7.4 BrammerBio Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 BrammerBio Recent Developments/Updates
        7.7.6 BrammerBio Competitive Strengths & Weaknesses
    7.8 CELLfor CURE
        7.8.1 CELLfor CURE Details
        7.8.2 CELLfor CURE Major Business
        7.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Product and Services
        7.8.4 CELLfor CURE Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 CELLfor CURE Recent Developments/Updates
        7.8.6 CELLfor CURE Competitive Strengths & Weaknesses
    7.9 OBiO Technology
        7.9.1 OBiO Technology Details
        7.9.2 OBiO Technology Major Business
        7.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Product and Services
        7.9.4 OBiO Technology Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 OBiO Technology Recent Developments/Updates
        7.9.6 OBiO Technology Competitive Strengths & Weaknesses
    7.10 GenScript
        7.10.1 GenScript Details
        7.10.2 GenScript Major Business
        7.10.3 GenScript Cell and Gene Therapy CDMO Services Product and Services
        7.10.4 GenScript Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 GenScript Recent Developments/Updates
        7.10.6 GenScript Competitive Strengths & Weaknesses
    7.11 Esco
        7.11.1 Esco Details
        7.11.2 Esco Major Business
        7.11.3 Esco Cell and Gene Therapy CDMO Services Product and Services
        7.11.4 Esco Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Esco Recent Developments/Updates
        7.11.6 Esco Competitive Strengths & Weaknesses
    7.12 Nikon
        7.12.1 Nikon Details
        7.12.2 Nikon Major Business
        7.12.3 Nikon Cell and Gene Therapy CDMO Services Product and Services
        7.12.4 Nikon Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Nikon Recent Developments/Updates
        7.12.6 Nikon Competitive Strengths & Weaknesses
    7.13 FUJIFILM
        7.13.1 FUJIFILM Details
        7.13.2 FUJIFILM Major Business
        7.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Product and Services
        7.13.4 FUJIFILM Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 FUJIFILM Recent Developments/Updates
        7.13.6 FUJIFILM Competitive Strengths & Weaknesses
    7.14 Pharmaron
        7.14.1 Pharmaron Details
        7.14.2 Pharmaron Major Business
        7.14.3 Pharmaron Cell and Gene Therapy CDMO Services Product and Services
        7.14.4 Pharmaron Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Pharmaron Recent Developments/Updates
        7.14.6 Pharmaron Competitive Strengths & Weaknesses
    7.15 Porton
        7.15.1 Porton Details
        7.15.2 Porton Major Business
        7.15.3 Porton Cell and Gene Therapy CDMO Services Product and Services
        7.15.4 Porton Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Porton Recent Developments/Updates
        7.15.6 Porton Competitive Strengths & Weaknesses
    7.16 Medicilon
        7.16.1 Medicilon Details
        7.16.2 Medicilon Major Business
        7.16.3 Medicilon Cell and Gene Therapy CDMO Services Product and Services
        7.16.4 Medicilon Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Medicilon Recent Developments/Updates
        7.16.6 Medicilon Competitive Strengths & Weaknesses
    7.17 JOINN Laboratories
        7.17.1 JOINN Laboratories Details
        7.17.2 JOINN Laboratories Major Business
        7.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Product and Services
        7.17.4 JOINN Laboratories Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 JOINN Laboratories Recent Developments/Updates
        7.17.6 JOINN Laboratories Competitive Strengths & Weaknesses
    7.18 Sofpromed
        7.18.1 Sofpromed Details
        7.18.2 Sofpromed Major Business
        7.18.3 Sofpromed Cell and Gene Therapy CDMO Services Product and Services
        7.18.4 Sofpromed Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Sofpromed Recent Developments/Updates
        7.18.6 Sofpromed Competitive Strengths & Weaknesses
    7.19 eXmoor
        7.19.1 eXmoor Details
        7.19.2 eXmoor Major Business
        7.19.3 eXmoor Cell and Gene Therapy CDMO Services Product and Services
        7.19.4 eXmoor Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 eXmoor Recent Developments/Updates
        7.19.6 eXmoor Competitive Strengths & Weaknesses
    7.20 OmniaBio
        7.20.1 OmniaBio Details
        7.20.2 OmniaBio Major Business
        7.20.3 OmniaBio Cell and Gene Therapy CDMO Services Product and Services
        7.20.4 OmniaBio Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.20.5 OmniaBio Recent Developments/Updates
        7.20.6 OmniaBio Competitive Strengths & Weaknesses
    7.21 RoslinCT
        7.21.1 RoslinCT Details
        7.21.2 RoslinCT Major Business
        7.21.3 RoslinCT Cell and Gene Therapy CDMO Services Product and Services
        7.21.4 RoslinCT Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.21.5 RoslinCT Recent Developments/Updates
        7.21.6 RoslinCT Competitive Strengths & Weaknesses
    7.22 BioCentriq
        7.22.1 BioCentriq Details
        7.22.2 BioCentriq Major Business
        7.22.3 BioCentriq Cell and Gene Therapy CDMO Services Product and Services
        7.22.4 BioCentriq Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.22.5 BioCentriq Recent Developments/Updates
        7.22.6 BioCentriq Competitive Strengths & Weaknesses
    7.23 PolTREG
        7.23.1 PolTREG Details
        7.23.2 PolTREG Major Business
        7.23.3 PolTREG Cell and Gene Therapy CDMO Services Product and Services
        7.23.4 PolTREG Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.23.5 PolTREG Recent Developments/Updates
        7.23.6 PolTREG Competitive Strengths & Weaknesses
    7.24 Miltenyi Bioindustry
        7.24.1 Miltenyi Bioindustry Details
        7.24.2 Miltenyi Bioindustry Major Business
        7.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product and Services
        7.24.4 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        7.24.5 Miltenyi Bioindustry Recent Developments/Updates
        7.24.6 Miltenyi Bioindustry Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy CDMO Services Industry Chain
    8.2 Cell and Gene Therapy CDMO Services Upstream Analysis
    8.3 Cell and Gene Therapy CDMO Services Midstream Analysis
    8.4 Cell and Gene Therapy CDMO Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Cell and Gene Therapy CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Cell and Gene Therapy CDMO Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Cell and Gene Therapy CDMO Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Cell and Gene Therapy CDMO Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Cell and Gene Therapy CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Cell and Gene Therapy CDMO Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Cell and Gene Therapy CDMO Services Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Cell and Gene Therapy CDMO Services Players in 2023
 Table 12. World Cell and Gene Therapy CDMO Services Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Cell and Gene Therapy CDMO Services Company Evaluation Quadrant
 Table 14. Head Office of Key Cell and Gene Therapy CDMO Services Players
 Table 15. Cell and Gene Therapy CDMO Services Market: Company Product Type Footprint
 Table 16. Cell and Gene Therapy CDMO Services Market: Company Product Application Footprint
 Table 17. Cell and Gene Therapy CDMO Services Mergers & Acquisitions Activity
 Table 18. United States VS China Cell and Gene Therapy CDMO Services Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Cell and Gene Therapy CDMO Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Cell and Gene Therapy CDMO Services Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Cell and Gene Therapy CDMO Services Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Cell and Gene Therapy CDMO Services Revenue Market Share (2019-2024)
 Table 23. China Based Cell and Gene Therapy CDMO Services Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Cell and Gene Therapy CDMO Services Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Cell and Gene Therapy CDMO Services Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Cell and Gene Therapy CDMO Services Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Cell and Gene Therapy CDMO Services Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Cell and Gene Therapy CDMO Services Revenue Market Share (2019-2024)
 Table 29. World Cell and Gene Therapy CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Cell and Gene Therapy CDMO Services Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Cell and Gene Therapy CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030) & (USD Million)
 Table 35. Catalent Basic Information, Manufacturing Base and Competitors
 Table 36. Catalent Major Business
 Table 37. Catalent Cell and Gene Therapy CDMO Services Product and Services
 Table 38. Catalent Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Catalent Recent Developments/Updates
 Table 40. Catalent Competitive Strengths & Weaknesses
 Table 41. Lonza Basic Information, Manufacturing Base and Competitors
 Table 42. Lonza Major Business
 Table 43. Lonza Cell and Gene Therapy CDMO Services Product and Services
 Table 44. Lonza Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Lonza Recent Developments/Updates
 Table 46. Lonza Competitive Strengths & Weaknesses
 Table 47. Thermo Fisher Basic Information, Manufacturing Base and Competitors
 Table 48. Thermo Fisher Major Business
 Table 49. Thermo Fisher Cell and Gene Therapy CDMO Services Product and Services
 Table 50. Thermo Fisher Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Thermo Fisher Recent Developments/Updates
 Table 52. Thermo Fisher Competitive Strengths & Weaknesses
 Table 53. WuXi AppTec Basic Information, Manufacturing Base and Competitors
 Table 54. WuXi AppTec Major Business
 Table 55. WuXi AppTec Cell and Gene Therapy CDMO Services Product and Services
 Table 56. WuXi AppTec Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. WuXi AppTec Recent Developments/Updates
 Table 58. WuXi AppTec Competitive Strengths & Weaknesses
 Table 59. Charles River Basic Information, Manufacturing Base and Competitors
 Table 60. Charles River Major Business
 Table 61. Charles River Cell and Gene Therapy CDMO Services Product and Services
 Table 62. Charles River Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Charles River Recent Developments/Updates
 Table 64. Charles River Competitive Strengths & Weaknesses
 Table 65. OxfordBioMedica Basic Information, Manufacturing Base and Competitors
 Table 66. OxfordBioMedica Major Business
 Table 67. OxfordBioMedica Cell and Gene Therapy CDMO Services Product and Services
 Table 68. OxfordBioMedica Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. OxfordBioMedica Recent Developments/Updates
 Table 70. OxfordBioMedica Competitive Strengths & Weaknesses
 Table 71. BrammerBio Basic Information, Manufacturing Base and Competitors
 Table 72. BrammerBio Major Business
 Table 73. BrammerBio Cell and Gene Therapy CDMO Services Product and Services
 Table 74. BrammerBio Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. BrammerBio Recent Developments/Updates
 Table 76. BrammerBio Competitive Strengths & Weaknesses
 Table 77. CELLfor CURE Basic Information, Manufacturing Base and Competitors
 Table 78. CELLfor CURE Major Business
 Table 79. CELLfor CURE Cell and Gene Therapy CDMO Services Product and Services
 Table 80. CELLfor CURE Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. CELLfor CURE Recent Developments/Updates
 Table 82. CELLfor CURE Competitive Strengths & Weaknesses
 Table 83. OBiO Technology Basic Information, Manufacturing Base and Competitors
 Table 84. OBiO Technology Major Business
 Table 85. OBiO Technology Cell and Gene Therapy CDMO Services Product and Services
 Table 86. OBiO Technology Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. OBiO Technology Recent Developments/Updates
 Table 88. OBiO Technology Competitive Strengths & Weaknesses
 Table 89. GenScript Basic Information, Manufacturing Base and Competitors
 Table 90. GenScript Major Business
 Table 91. GenScript Cell and Gene Therapy CDMO Services Product and Services
 Table 92. GenScript Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. GenScript Recent Developments/Updates
 Table 94. GenScript Competitive Strengths & Weaknesses
 Table 95. Esco Basic Information, Manufacturing Base and Competitors
 Table 96. Esco Major Business
 Table 97. Esco Cell and Gene Therapy CDMO Services Product and Services
 Table 98. Esco Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Esco Recent Developments/Updates
 Table 100. Esco Competitive Strengths & Weaknesses
 Table 101. Nikon Basic Information, Manufacturing Base and Competitors
 Table 102. Nikon Major Business
 Table 103. Nikon Cell and Gene Therapy CDMO Services Product and Services
 Table 104. Nikon Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Nikon Recent Developments/Updates
 Table 106. Nikon Competitive Strengths & Weaknesses
 Table 107. FUJIFILM Basic Information, Manufacturing Base and Competitors
 Table 108. FUJIFILM Major Business
 Table 109. FUJIFILM Cell and Gene Therapy CDMO Services Product and Services
 Table 110. FUJIFILM Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. FUJIFILM Recent Developments/Updates
 Table 112. FUJIFILM Competitive Strengths & Weaknesses
 Table 113. Pharmaron Basic Information, Manufacturing Base and Competitors
 Table 114. Pharmaron Major Business
 Table 115. Pharmaron Cell and Gene Therapy CDMO Services Product and Services
 Table 116. Pharmaron Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Pharmaron Recent Developments/Updates
 Table 118. Pharmaron Competitive Strengths & Weaknesses
 Table 119. Porton Basic Information, Manufacturing Base and Competitors
 Table 120. Porton Major Business
 Table 121. Porton Cell and Gene Therapy CDMO Services Product and Services
 Table 122. Porton Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Porton Recent Developments/Updates
 Table 124. Porton Competitive Strengths & Weaknesses
 Table 125. Medicilon Basic Information, Manufacturing Base and Competitors
 Table 126. Medicilon Major Business
 Table 127. Medicilon Cell and Gene Therapy CDMO Services Product and Services
 Table 128. Medicilon Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 129. Medicilon Recent Developments/Updates
 Table 130. Medicilon Competitive Strengths & Weaknesses
 Table 131. JOINN Laboratories Basic Information, Manufacturing Base and Competitors
 Table 132. JOINN Laboratories Major Business
 Table 133. JOINN Laboratories Cell and Gene Therapy CDMO Services Product and Services
 Table 134. JOINN Laboratories Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 135. JOINN Laboratories Recent Developments/Updates
 Table 136. JOINN Laboratories Competitive Strengths & Weaknesses
 Table 137. Sofpromed Basic Information, Manufacturing Base and Competitors
 Table 138. Sofpromed Major Business
 Table 139. Sofpromed Cell and Gene Therapy CDMO Services Product and Services
 Table 140. Sofpromed Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 141. Sofpromed Recent Developments/Updates
 Table 142. Sofpromed Competitive Strengths & Weaknesses
 Table 143. eXmoor Basic Information, Manufacturing Base and Competitors
 Table 144. eXmoor Major Business
 Table 145. eXmoor Cell and Gene Therapy CDMO Services Product and Services
 Table 146. eXmoor Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 147. eXmoor Recent Developments/Updates
 Table 148. eXmoor Competitive Strengths & Weaknesses
 Table 149. OmniaBio Basic Information, Manufacturing Base and Competitors
 Table 150. OmniaBio Major Business
 Table 151. OmniaBio Cell and Gene Therapy CDMO Services Product and Services
 Table 152. OmniaBio Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 153. OmniaBio Recent Developments/Updates
 Table 154. OmniaBio Competitive Strengths & Weaknesses
 Table 155. RoslinCT Basic Information, Manufacturing Base and Competitors
 Table 156. RoslinCT Major Business
 Table 157. RoslinCT Cell and Gene Therapy CDMO Services Product and Services
 Table 158. RoslinCT Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 159. RoslinCT Recent Developments/Updates
 Table 160. RoslinCT Competitive Strengths & Weaknesses
 Table 161. BioCentriq Basic Information, Manufacturing Base and Competitors
 Table 162. BioCentriq Major Business
 Table 163. BioCentriq Cell and Gene Therapy CDMO Services Product and Services
 Table 164. BioCentriq Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 165. BioCentriq Recent Developments/Updates
 Table 166. BioCentriq Competitive Strengths & Weaknesses
 Table 167. PolTREG Basic Information, Manufacturing Base and Competitors
 Table 168. PolTREG Major Business
 Table 169. PolTREG Cell and Gene Therapy CDMO Services Product and Services
 Table 170. PolTREG Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 171. PolTREG Recent Developments/Updates
 Table 172. PolTREG Competitive Strengths & Weaknesses
 Table 173. Miltenyi Bioindustry Basic Information, Manufacturing Base and Competitors
 Table 174. Miltenyi Bioindustry Major Business
 Table 175. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product and Services
 Table 176. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 177. Miltenyi Bioindustry Recent Developments/Updates
 Table 178. Miltenyi Bioindustry Competitive Strengths & Weaknesses
 Table 179. Global Key Players of Cell and Gene Therapy CDMO Services Upstream (Raw Materials)
 Table 180. Global Cell and Gene Therapy CDMO Services Typical Customers


List of Figures
 Figure 1. Cell and Gene Therapy CDMO Services Picture
 Figure 2. World Cell and Gene Therapy CDMO Services Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Cell and Gene Therapy CDMO Services Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Cell and Gene Therapy CDMO Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Cell and Gene Therapy CDMO Services Revenue (2019-2030) & (USD Million)
 Figure 13. Cell and Gene Therapy CDMO Services Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Cell and Gene Therapy CDMO Services Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Cell and Gene Therapy CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Cell and Gene Therapy CDMO Services by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy CDMO Services Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy CDMO Services Markets in 2023
 Figure 27. United States VS China: Cell and Gene Therapy CDMO Services Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Cell and Gene Therapy CDMO Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Cell and Gene Therapy CDMO Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Cell and Gene Therapy CDMO Services Market Size Market Share by Type in 2023
 Figure 31. Autologous Cell Therapy Products
 Figure 32. Allogeneic Cell Therapy Products
 Figure 33. World Cell and Gene Therapy CDMO Services Market Size Market Share by Type (2019-2030)
 Figure 34. World Cell and Gene Therapy CDMO Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Cell and Gene Therapy CDMO Services Market Size Market Share by Application in 2023
 Figure 36. SMBs
 Figure 37. Large Companies
 Figure 38. World Cell and Gene Therapy CDMO Services Market Size Market Share by Application (2019-2030)
 Figure 39. Cell and Gene Therapy CDMO Services Industrial Chain
 Figure 40. Methodology
 Figure 41. Research Process and Data Source

Companies Mentioned

Catalent
Lonza
Thermo Fisher
WuXi AppTec
Charles River
OxfordBioMedica
BrammerBio
CELLfor CURE
OBiO Technology
GenScript
Esco
Nikon
FUJIFILM
Pharmaron
Porton
Medicilon
JOINN Laboratories
Sofpromed
eXmoor
OmniaBio
RoslinCT
BioCentriq
PolTREG
Miltenyi Bioindustry